BIO Bio-Rad Laboratories, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

BIO [NYSE]

Bio-Rad Laboratories, Inc.

Healthcare | Medical Devices | USA

statements

Index	S&P 500	P/E	10.07	EPS (ttm)	52.17	Insider Own	1.70%	Shs Outstand	29.87M	Perf Week	-1.94%
Market Cap	15.90B	Forward P/E	53.04	EPS next Y	9.90	Insider Trans	-0.38%	Shs Float	21.20M	Perf Month	12.35%
Income	1.58B	PEG	0.57	EPS next Q	1.60	Inst Own	77.80%	Short Float	2.72%	Perf Quarter	14.07%
Sales	2.33B	P/S	6.83	EPS this Y	456.30%	Inst Trans	0.05%	Short Ratio	2.06	Perf Half Y	40.34%
Book/sh	210.72	P/B	2.49	EPS next Y	30.77%	ROA	22.30%	Target Price	536.25	Perf Year	63.95%
Cash/sh	34.24	P/C	15.34	EPS next 5Y	17.80%	ROE	31.00%	52W Range	309.38 - 540.06	Perf YTD	41.94%
Dividend	-	P/FCF	44.25	EPS past 5Y	80.40%	ROI	-4.50%	52W High	-2.75%	Beta	1.12
Dividend %	-	Quick Ratio	1.80	Sales past 5Y	1.20%	Gross Margin	54.30%	52W Low	69.77%	ATR	13.61
Employees	8120	Current Ratio	2.40	Sales Q/Q	3.20%	Oper. Margin	9.60%	RSI (14)	61.47	Volatility	2.70% 2.57%
Optionable	Yes	Debt/Eq	0.07	EPS Q/Q	-21.00%	Profit Margin	75.50%	Rel Volume	0.47	Prev Close	527.30
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Jul 30 AMC	Payout	0.00%	Avg Volume	280.40K	Price	525.22
Recom	1.50	SMA20	2.44%	SMA50	9.34%	SMA200	29.57%	Volume	132,209	Change	-0.39%

Jan-08-20

Initiated

Wells Fargo

Overweight

$430

Jan-07-20

Initiated

Citigroup

Buy

$450

Oct-17-18

Initiated

Goldman

Buy

$350

Sep-20-18

Initiated

Morgan Stanley

Equal-Weight

$335

Feb-16-18

Downgrade

CL King

Buy → Neutral

Jul-13-17

Initiated

Wells Fargo

Outperform

Jun-28-17

Upgrade

Deutsche Bank

Hold → Buy

$220 → $255

Jan-18-17

Initiated

Deutsche Bank

Hold

$195

Oct-13-16

Initiated

CL King

Buy

May-06-15

Reiterated

Jefferies

Buy

$150 → $165

Dec-18-09

Initiated

Maxim Group

Buy

$125

Nov-06-09

Initiated

Jefferies & Co

Buy

$130

Jul-17-09

Initiated

Soleil

Buy

$91

Sep-26-07

Initiated

Banc of America Sec

Buy

$110

Feb-23-07

Downgrade

Robert W. Baird

Outperform → Neutral

$83 → $76

Aug-04-20 08:30AM	The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Courts Award of Damages Business Wire
Jul-31-20 08:33PM	Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript Motley Fool
10:36AM	Bio-Rad (BIO) Q2 Earnings Beat Estimates, Gross Margin Rises Zacks
Jul-30-20 05:45PM	Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Surpass Estimates Zacks
04:15PM	Bio-Rad Reports Second-Quarter 2020 Financial Results Business Wire
Jul-29-20 09:16AM	Medical Products Stock Earnings on Jul 30: BAX, SYK & More Zacks
Jul-28-20 03:18PM	Top Health Care Stocks for August 2020 Investopedia
Jul-27-20 08:29AM	Bio-Rad (BIO) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-24-20 07:31PM	Earnings Season Watch List: Bio Rad Labs Hits New Highs Investor's Business Daily
Jul-23-20 12:32PM	Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-15-20 08:01PM	Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020 Business Wire
Jul-13-20 08:12PM	Did Hedge Funds Make The Right Call On Bio-Rad Laboratories, Inc. (BIO) ? Insider Monkey
Jul-09-20 03:57PM	Biomarin's Hemophilia A Drug Among 5 Up for FDA Approval Soon GuruFocus.com
09:32AM	Bio-Rad (BIO) Banks on Coronavirus PCR Tests Amid Cost Woes Zacks
Jun-30-20 05:18PM	3 Health Care Companies That Beat the Market in the 1st Half of the Year GuruFocus.com
10:40AM	Bio-Rad Rides on PCR Test Kits for Coronavirus Amid Cost Woe Zacks
Jun-15-20 11:31AM	T. Rowe Price and Align Technology Show High Profit, Low Debt GuruFocus.com
Jun-12-20 06:18PM	S&P Dow Jones Indices Announces Tyler Technologies, Bio-Rad Laboratories and Teledyne Technologies Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire
Jun-11-20 07:30PM	RPT-Outbreak quashed, China launches test lab spending spree Reuters -6.44%
06:00AM	Outbreak quashed, China launches test lab spending spree Reuters
Jun-08-20 10:22AM	Bio-Rad Rides on New Coronavirus Tests Amid Cost Concerns Zacks
Jun-05-20 10:00AM	Why Coronavirus Testing Stocks Are Among 4 Key Health Care Stocks Investor's Business Daily
Jun-01-20 09:07AM	Do Hedge Funds Love Bio-Rad Laboratories, Inc. (BIO)? Insider Monkey
May-15-20 03:06PM	Bio-Rad Laboratories, Inc. -- Moody's announces completion of a periodic review of ratings of Bio-Rad Laboratories, Inc. Moody's
May-13-20 03:34PM	12 health-care stocks that will be winners because of coronavirus-led trends, according to Jefferies MarketWatch
May-12-20 11:51AM	Jefferies Picks 20 Global Health-Care Winners for a Post-Pandemic World Barrons.com
May-07-20 06:06PM	Bio-Rad Laboratories Inc (BIO) (BIO.B) Q1 2020 Earnings Call Transcript Motley Fool
10:11AM	Bio-Rad (BIO) Beats Q1 Earnings Estimates, Withdraws View Zacks
May-06-20 08:25PM	Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Surpass Estimates Zacks
04:15PM	Bio-Rad Reports First-Quarter 2020 Financial Results Business Wire
May-05-20 08:00AM	The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout Benzinga
May-04-20 07:27PM	Bio-Rad Receives FDA Emergency Use Authorization for Droplet Digital PCR SARS-CoV-2 Test Kit Business Wire
11:12AM	Were Hedge Funds Right About Bio-Rad Laboratories, Inc. (BIO)? Insider Monkey
May-03-20 03:37PM	A Potentially Undervalued Trio to Consider GuruFocus.com
Apr-30-20 04:51PM	Bio-Rads SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA Business Wire
09:00AM	Yahoo Finance Presents: Joe Lonsdale Yahoo Finance Video
Apr-29-20 12:34PM	Earnings Preview: Bio-Rad Laboratories (BIO) Q1 Earnings Expected to Decline Zacks
Apr-27-20 08:00AM	Top Investors' Favorite Stocks Rally Amid Coronavirus Crash Investor's Business Daily
06:16AM	A Rising Share Price Has Us Looking Closely At Bio-Rad Laboratories, Inc.'s (NYSE:BIO) P/E Ratio Simply Wall St.
Apr-23-20 06:44PM	Bio Rad Labs At Top End Of Buy Range With Earnings Due Investor's Business Daily
Apr-22-20 04:25PM	Bio-Rad to Report First-Quarter 2020 Financial Results Wednesday, May 6, 2020 Business Wire
Apr-21-20 10:35AM	Bio-Rad Laboratories Rolls Out Shipping of Coronavirus Antibody Test SmarterAnalyst
08:30AM	Bio-Rad Begins Shipping SARS-COV-2 (COVID-19) Antibody Test That Offers More Than 99 Percent Specificity and 98 Percent Sensitivity Business Wire
Apr-09-20 09:35AM	Bio-Rad Rides on International Expansion Amid Cost Concerns Zacks
09:23AM	Bio-Rad Launches Serology Test to Detect Coronavirus Antibody Zacks
08:30AM	Bio-Rad Acquires Celsee, Inc., a Single-Cell Analysis Solutions Provider Business Wire
Apr-08-20 10:34AM	Bio-Rad Coronavirus Blood Test 'Could be Big,' Jefferies Says TheStreet.com +8.83%
06:57AM	Do You Like Bio-Rad Laboratories, Inc. (NYSE:BIO) At This P/E Ratio? Simply Wall St.
Apr-07-20 08:30AM	Bio-Rad Announces the Launch of a Serology Assay to Detect Coronavirus (COVID-19) Antibodies Business Wire
Apr-06-20 01:55PM	5 Peter Lynch Stocks With a Margin of Safety GuruFocus.com
Apr-02-20 09:42AM	East Bay biotech hit by ransomware attack just 3 months after competitor hacked American City Business Journals +7.73%
Mar-31-20 08:00AM	Top Fund Manager Says These Stocks Should Soar In The Next Market Rally Investor's Business Daily
Mar-23-20 06:16PM	3 Medical Companies With the Strength to Weather Coronavirus Fears GuruFocus.com
11:16AM	Bio-Rad, Biodesix Partner to Get EUA for Coronavirus Test Zacks
Mar-20-20 10:43AM	Bio-Rad's ddPCR System Detects Coronavirus More Accurately Zacks -5.13%
07:00AM	Biodesix Partners with Bio-Rad to Bring Emergency Use Authorization (EUA) COVID-19 ddPCR Test to the U.S. Business Wire
Mar-19-20 05:30PM	New Studies Find Bio-Rads QX200 Droplet Digital PCR System Can Detect COVID-19 With Greater Sensitivity and Precision Than Other Existing Molecular Tests Business Wire
07:37AM	The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection Benzinga
Mar-18-20 07:24PM	Bio-Rad Partners with Testing Labs Worldwide to Support COVID-19 Testing Business Wire
Mar-17-20 11:27AM	Hedge Funds Have Never Been More Bullish On Bio-Rad Laboratories, Inc. (BIO) Insider Monkey +6.87%
Mar-14-20 11:30AM	Why Is Bio-Rad (BIO) Down 8.3% Since Last Earnings Report? Zacks
Mar-13-20 09:45AM	Bio-Rad Launches SARS CoV-2 Standard for Coronavirus Testing Zacks +8.68%
Mar-12-20 07:30PM	Bio-Rad Announces that Through its Exact Diagnostics Product Line, the Company has Launched a SARS CoV-2 Standard for Coronavirus (COVID-19) Testing Business Wire -7.46%
Mar-09-20 01:30PM	6 Cheap Health Care Stocks GuruFocus.com -6.20%
08:34AM	With EPS Growth And More, Bio-Rad Laboratories (NYSE:BIO) Is Interesting Simply Wall St.
Feb-25-20 04:15PM	Bio-Rad to Present at Barclays Global Healthcare Conference 2020 on March 10 Business Wire
Feb-24-20 05:47PM	As coronavirus fears hit markets, why are these Bay Area stocks rising? American City Business Journals
Feb-18-20 06:31PM	Edited Transcript of BIO earnings conference call or presentation 13-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-14-20 10:35AM	Cyberattack costs East Bay biotech company $20 million American City Business Journals +6.40%
08:53AM	Bio-Rad (BIO) Q4 Earnings & Revenues Fall Short of Estimates Zacks
Feb-13-20 06:45PM	Bio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue Estimates Zacks
06:23PM	CORRECTING and REPLACING Bio-Rad Reports Fourth-Quarter and Full-Year 2019 Financial Results Business Wire
Feb-06-20 12:30PM	Bio-Rad Laboratories (BIO) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Feb-04-20 07:00AM	Bio-Rad Brings FCS Express Flow Cytometry Analysis Software to ZE5 Cell Analyzer Users ACCESSWIRE
Feb-03-20 09:37PM	Bio-Rad to Report Fourth-Quarter and Full-Year 2019 Financial Results Thursday, February 13, 2020 Business Wire
Jan-09-20 05:40AM	Is Bio-Rad Laboratories, Inc.'s (NYSE:BIO) ROE Of 7.3% Concerning? Simply Wall St.
Jan-06-20 08:30AM	Bio-Rad Appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President Business Wire
Jan-02-20 04:15PM	Bio-Rad to Participate at the 38th Annual J.P. Morgan Healthcare Conference on January 13 Business Wire
Dec-30-19 11:47AM	Bio-Rad Gains on New Product Portfolio Despite Currency Woes Zacks
Dec-25-19 02:35PM	Bio-Rad Laboratories, Inc. (BIO) vs. Top 20 Hedge Fund Stocks in 2019 Insider Monkey
Dec-23-19 08:30AM	The International Trade Commission Issues Final Decision Affirming 10X Genomics Infringement of Three of Bio-Rads Patents Business Wire
Dec-13-19 04:52PM	Bio-Rad Makes Progress Recovering from Recent Ransomware Attack Business Wire
Dec-11-19 05:23AM	Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching Simply Wall St.
Dec-02-19 08:40PM	Edited Transcript of BIO earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Nov-30-19 02:28PM	Hedge Funds Have Never Been This Bullish On Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Nov-26-19 12:11PM	Bio-Rad's Blood Typing Market Growth Strong on New Products Zacks
Nov-18-19 01:17AM	Edited Transcript of BIO earnings conference call or presentation 31-Oct-19 9:00pm GMT Thomson Reuters StreetEvents
Nov-11-19 07:49AM	Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet? Simply Wall St.
Nov-01-19 12:03PM	Bio-Rad (Bio) Q3 Earnings Beat Estimates on All-Line Growth Zacks +6.25%
Oct-31-19 06:15PM	Bio-Rad Laboratories (BIO) Q3 Earnings Beat Estimates Zacks
04:15PM	Bio-Rad Reports Third-Quarter 2019 Financial Results Business Wire
Oct-29-19 05:09PM	This Hedge Fund Can Still Deliver Double Digit Returns: Here Are Its Top Picks Insider Monkey
Oct-24-19 10:32AM	Bio-Rad Laboratories (BIO) Earnings Expected to Grow: Should You Buy? Zacks
Oct-23-19 11:13AM	5 Companies Hit 52-Week Highs GuruFocus.com
Oct-16-19 04:15PM	Bio-Rad to Report Third-Quarter 2019 Financial Results Thursday, October 31, 2019 Business Wire
Oct-15-19 12:05PM	5 Stocks to Buy in the Mighty Middle InvestorPlace
Oct-12-19 03:34PM	Heres What Hedge Funds Think About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Oct-08-19 10:36AM	LabCorp (LH) Names Two Leaders for Major Business Wings Zacks -5.55%
Oct-07-19 06:36AM	Bruker To Buy Freiberg Instruments' Magnettech EPR Business Zacks
Oct-02-19 09:48AM	Abbott (ABT) Gets FDA Nod for New Troponin-I Blood Test Zacks

Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHWARTZ NORMAN D	Chairman, President, and CEO	Jun 12	Option Exercise	84.57	37,000	3,129,090	316,982	Jun 15 07:02 PM
Crowley Michael	EVP, GBL Commercial Operations	Jun 01	Sale	485.40	1,500	728,100	2,310	Jun 02 05:11 PM
HUTTON RONALD W	Vice President and Treasurer	May 13	Sale	457.35	443	202,606	4,140	May 14 01:11 PM
Last Andrew J.	EVP, Chief Operating Officer	Apr 29	Option Exercise	0.00	1,000	0	1,026	Apr 30 02:14 PM
Daskal Ilan	EVP, Chief Financial Officer	Apr 08	Option Exercise	0.00	700	0	700	Apr 09 01:07 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Dec 04	Option Exercise	159.32	1,250	199,150	2,362	Dec 05 07:03 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Dec 04	Sale	370.11	1,906	705,436	456	Dec 05 07:03 PM
STARK JAMES R	VP, Corporate Controller	Nov 11	Sale	351.45	848	298,030	0	Nov 12 11:33 AM
HERTIA JOHN	Executive Vice President	Sep 12	Option Exercise	129.55	1,200	155,460	19,566	Sep 13 11:54 AM
TUMOLO ANNETTE	Executive Vice President	Sep 12	Sale	330.00	522	172,260	2,410	Sep 16 06:05 PM
HERTIA JOHN	Executive Vice President	Sep 12	Sale	328.29	838	275,104	18,728	Sep 13 11:54 AM
HERTIA JOHN	Executive Vice President	Sep 11	Option Exercise	0.00	600	0	18,664	Sep 13 11:48 AM
Crowley Michael	EVP, GBL Commercial Operations	Sep 11	Option Exercise	0.00	600	0	4,041	Sep 12 03:59 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 11	Option Exercise	0.00	150	0	4,619	Sep 12 04:12 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 11	Option Exercise	0.00	500	0	15,065	Sep 12 04:15 PM
STARK JAMES R	VP, Corporate Controller	Sep 11	Option Exercise	0.00	300	0	952	Sep 12 04:19 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 11	Option Exercise	0.00	3,200	0	281,529	Sep 12 04:24 PM
TUMOLO ANNETTE	Executive Vice President	Sep 11	Option Exercise	0.00	600	0	3,170	Sep 12 04:29 PM
TUMOLO ANNETTE	Executive Vice President	Sep 10	Option Exercise	0.00	400	0	2,709	Sep 12 04:29 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 10	Option Exercise	0.00	2,000	0	279,321	Sep 12 04:24 PM
STARK JAMES R	VP, Corporate Controller	Sep 10	Option Exercise	0.00	200	0	722	Sep 12 04:19 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 10	Option Exercise	0.00	400	0	14,764	Sep 12 04:15 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 10	Option Exercise	0.00	150	0	4,521	Sep 12 04:12 PM
HERTIA JOHN	Executive Vice President	Sep 10	Option Exercise	0.00	600	0	18,362	Sep 12 04:07 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 10	Option Exercise	0.00	389	0	3,576	Sep 12 03:59 PM
HERTIA JOHN	Executive Vice President	Sep 09	Option Exercise	159.32	600	95,592	18,206	Sep 10 05:15 PM
HERTIA JOHN	Executive Vice President	Sep 09	Sale	336.47	444	149,393	17,762	Sep 10 05:15 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 08	Option Exercise	0.00	400	0	14,563	Sep 09 06:27 PM
STARK JAMES R	VP, Corporate Controller	Sep 07	Option Exercise	0.00	300	0	626	Sep 09 03:45 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 07	Option Exercise	0.00	500	0	1,257	Sep 09 05:08 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 07	Option Exercise	0.00	600	0	3,395	Sep 09 05:17 PM
TUMOLO ANNETTE	Executive Vice President	Sep 07	Option Exercise	0.00	600	0	2,517	Sep 09 05:36 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 07	Option Exercise	0.00	3,000	0	278,809	Sep 10 02:04 PM
HERTIA JOHN	Executive Vice President	Sep 07	Option Exercise	0.00	600	0	17,904	Sep 09 05:50 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 07	Option Exercise	0.00	170	0	4,430	Sep 09 06:11 PM
HERTIA JOHN	Executive Vice President	Sep 06	Option Exercise	164.47	7,200	1,184,154	22,499	Sep 09 05:50 PM
HERTIA JOHN	Executive Vice President	Sep 06	Sale	336.57	5,195	1,748,490	17,304	Sep 09 05:50 PM
TUMOLO ANNETTE	Executive Vice President	Sep 06	Sale	340.00	371	126,140	1,917	Sep 09 05:36 PM
TUMOLO ANNETTE	Executive Vice President	Sep 05	Option Exercise	0.00	600	0	2,496	Sep 09 05:36 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 05	Option Exercise	0.00	600	0	3,003	Sep 09 05:17 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 05	Option Exercise	0.00	500	0	930	Sep 09 05:08 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 05	Option Exercise	0.00	2,600	0	416,472	Sep 09 03:49 PM
STARK JAMES R	VP, Corporate Controller	Sep 05	Option Exercise	0.00	300	0	430	Sep 09 03:45 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 05	Option Exercise	0.00	500	0	14,411	Sep 09 03:40 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 05	Option Exercise	0.00	180	0	4,323	Sep 09 06:11 PM
HERTIA JOHN	Executive Vice President	Sep 05	Option Exercise	0.00	600	0	15,507	Sep 09 05:50 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 04	Option Exercise	0.00	600	0	2,611	Sep 05 02:00 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 04	Option Exercise	0.00	500	0	603	Sep 05 02:04 PM
TUMOLO ANNETTE	Executive Vice President	Sep 04	Option Exercise	0.00	600	0	2,104	Sep 05 02:52 PM
HERTIA JOHN	Executive Vice President	Sep 04	Option Exercise	0.00	600	0	15,115	Sep 05 05:26 PM
STARK JAMES R	VP, Corporate Controller	Sep 04	Option Exercise	0.00	200	0	200	Sep 05 02:22 PM
SCHWARTZ NORMAN D	Chairman, President and CEO	Sep 04	Option Exercise	0.00	2,600	0	415,162	Sep 05 02:17 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 04	Option Exercise	0.00	500	0	14,117	Sep 05 02:11 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 04	Option Exercise	0.00	180	0	4,206	Sep 05 02:07 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 04	Sale	333.08	1,089	362,723	2,011	Sep 05 02:00 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Aug 14	Sale	320.00	310	99,200	103	Aug 14 05:51 PM
Crowley Michael	EVP, GBL Commercial Operations	Aug 14	Sale	320.00	325	104,000	3,100	Aug 14 05:46 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience